• About Us
  • Copyright Policy
  • Disclaimer
  • Authors
  • Career
  • Contact Us
Assamese |   Bengali |  
Saturday, March 6, 2021
NORTHEAST NOW
  • HOME
  • NORTH EAST
    • Assam
    • Meghalaya
    • Tripura
    • Mizoram
    • Manipur
    • Nagaland
    • Arunachal
    • Sikkim
  • Neighbours
    • Nepal
    • Bhutan
    • China
    • Myanmar
    • Bangladesh
  • Business
  • Entertainment
  • Sports
  • Environment
  • Citizen Journalists
  • Opinion
No Result
View All Result
  • HOME
  • NORTH EAST
    • Assam
    • Meghalaya
    • Tripura
    • Mizoram
    • Manipur
    • Nagaland
    • Arunachal
    • Sikkim
  • Neighbours
    • Nepal
    • Bhutan
    • China
    • Myanmar
    • Bangladesh
  • Business
  • Entertainment
  • Sports
  • Environment
  • Citizen Journalists
  • Opinion
No Result
View All Result
NORTHEAST NOW
Assamese
Home Health

Johnson & Johnson to conduct human trials for COVID-19 vaccine by Sept

NE NOW NEWS by NE NOW NEWS
GUWAHATI , March 31, 2020 2:12 pm
Coronavirus

Representative photo.

Share on FacebookShare on Twitter

Popular pharmaceutical company Johnson & Johnson on Monday said it has selected a lead candidate vaccine for COVID-19 which would be used for human trials in September and be ready for emergency use by early next year.

The pharmaceutical company in partnership with the US Department of Health and Human Services has invested more than $1 billion for carrying out the research, development, and clinical testing of the vaccine.

The company began working on the vaccine under investigation — Ad26 SARS-CoV-2 — in January using the same technology it used to develop a candidate vaccine for Ebola.

Also read: COVID-19 epicentre: 299 from Assam attended Nizamuddin event in Delhi

Research teams of the company have collaborated with renowned scientists from multiple academic institutions including the Harvard Medical School to develop the vaccine.

“Johnson & Johnson has identified a lead COVID-19 vaccine candidate (with two back-ups), which will progress into the first manufacturing steps. Under an accelerated timeline, the Company is aiming to initiate a Phase 1 clinical study in September 2020, with clinical data on safety and efficacy expected to be available by the end of the year. This could allow vaccine availability for emergency use in early 2021,” the company said in a statement.

A number of educational institutions and companies are working to find a suitable treatment for COVID-19 which has claimed a number of human lives globally.

Tags: COVID19
Former Assam CM Prafulla Mahanta admitted to hospital in Guwahati

Assam Assembly election: Ex-CM Prafulla Mahanta among four sitting AGP MLAs denied ticket

Mizoram BJP refutes former party leader’s embezzlement charge

Assam Assembly elections: BJP denies ticket to 12 sitting MLAs

Assam: I stand with anti-CAA forces, says Prafulla Kumar Mahanta upon arrival in Guwahati

Assam: I stand with anti-CAA forces, says Prafulla Kumar Mahanta upon arrival in Guwahati

Standoff continues in Nepal over PM Oli’s resignation demand

Nepal PM KP Sarma Oli faces no-confidence motion by his own party

NORTHEAST NOW

Northeast Now is a multi-app based hyper-regional bilingual news portal. Led by a group of professionals, the digital news platform covers every inch of the eight states of northeast India and the five neighbouring countries. It is the first of its kind new media initiative in the northeast, and is based in Guwahati. As the political dynamics in the northeast is intricate and fluid, Northeast Now is always politically neutral.

 
Our Properties
 
  • NORTHEAST NOW ASSAMESE
  • NORTHEAST JOBS
  • NORTHEAST TENDERS
  • INNFINITY
  • About Us
  • Copyright Policy
  • Disclaimer
  • Authors
  • Career
  • Contact Us

© 2019 - Maintained by EZEN Software & Technology Pvt. Ltd

No Result
View All Result
  • HOME
  • NORTH EAST
    • Assam
    • Meghalaya
    • Tripura
    • Mizoram
    • Manipur
    • Nagaland
    • Arunachal
    • Sikkim
  • Neighbours
    • Nepal
    • Bhutan
    • China
    • Myanmar
    • Bangladesh
  • Business
  • Entertainment
  • Sports
  • Environment
  • Citizen Journalists
  • Opinion

© 2019 - Maintained by EZEN Software & Technology Pvt. Ltd